Bio-Rad Laboratories Long Term Debt 2010-2023 | BIO
Bio-Rad Laboratories long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
- Bio-Rad Laboratories long term debt for the quarter ending December 31, 2023 was $1.199B, a 0.11% increase year-over-year.
- Bio-Rad Laboratories long term debt for 2023 was $1.199B, a 0.11% increase from 2022.
- Bio-Rad Laboratories long term debt for 2022 was $1.198B, a 11291.63% increase from 2021.
- Bio-Rad Laboratories long term debt for 2021 was $0.011B, a 14.23% decline from 2020.
| Bio-Rad Laboratories Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $1,199 |
| 2022 | $1,198 |
| 2021 | $11 |
| 2020 | $12 |
| 2019 | $14 |
| 2018 | $439 |
| 2017 | $435 |
| 2016 | $434 |
| 2015 | $434 |
| 2014 | $436 |
| 2013 | $436 |
| 2012 | $732 |
| 2011 | $732 |
| 2010 | $731 |
| 2009 | $738 |
| Bio-Rad Laboratories Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2023-12-31 | $1,199 |
| 2023-09-30 | $1,199 |
| 2023-06-30 | $1,198 |
| 2023-03-31 | $1,198 |
| 2022-12-31 | $1,198 |
| 2022-09-30 | $1,197 |
| 2022-06-30 | $1,197 |
| 2022-03-31 | $1,197 |
| 2021-12-31 | $11 |
| 2021-09-30 | $11 |
| 2021-06-30 | $11 |
| 2021-03-31 | $11 |
| 2020-12-31 | $12 |
| 2020-09-30 | $12 |
| 2020-06-30 | $12 |
| 2020-03-31 | $12 |
| 2019-12-31 | $14 |
| 2019-09-30 | $438 |
| 2019-06-30 | $438 |
| 2019-03-31 | $438 |
| 2018-12-31 | $439 |
| 2018-09-30 | $439 |
| 2018-06-30 | $439 |
| 2018-03-31 | $435 |
| 2017-12-31 | $435 |
| 2017-09-30 | $434 |
| 2017-06-30 | $434 |
| 2017-03-31 | $434 |
| 2016-12-31 | $434 |
| 2016-09-30 | $434 |
| 2016-06-30 | $434 |
| 2016-03-31 | $434 |
| 2015-12-31 | $434 |
| 2015-09-30 | $436 |
| 2015-06-30 | $436 |
| 2015-03-31 | $436 |
| 2014-12-31 | $436 |
| 2014-09-30 | $436 |
| 2014-06-30 | $436 |
| 2014-03-31 | $436 |
| 2013-12-31 | $436 |
| 2013-09-30 | $436 |
| 2013-06-30 | $733 |
| 2013-03-31 | $733 |
| 2012-12-31 | $732 |
| 2012-09-30 | $732 |
| 2012-06-30 | $732 |
| 2012-03-31 | $732 |
| 2011-12-31 | $732 |
| 2011-09-30 | $732 |
| 2011-06-30 | $731 |
| 2011-03-31 | $731 |
| 2010-12-31 | $731 |
| 2010-09-30 | $734 |
| 2010-06-30 | $734 |
| 2010-03-31 | $739 |
| 2009-12-31 | $738 |
| 2009-09-30 | $739 |
| 2009-06-30 | $738 |
| 2009-03-31 | $444 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.977B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
| Stryker (SYK) | United States | $123.816B | 30.70 |
| Medtronic (MDT) | Ireland | $105.535B | 14.94 |
| Boston Scientific (BSX) | United States | $98.780B | 32.84 |
| EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
| ResMed (RMD) | United States | $26.307B | 26.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
| Terumo (TRUMY) | Japan | $24.492B | 34.59 |
| Baxter (BAX) | United States | $20.044B | 14.62 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.641B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.422B | 0.00 |
| Demant (WILYY) | Denmark | $9.965B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
| Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
| Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
| Haemonetics (HAE) | United States | $4.126B | 21.10 |
| GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
| Envista Holdings (NVST) | United States | $3.430B | 13.05 |
| QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
| Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
| Neogen (NEOG) | United States | $2.515B | 24.19 |
| ICU Medical (ICUI) | United States | $2.333B | 17.41 |
| TG Therapeutics (TGTX) | United States | $2.130B | 689.00 |
| Owens & Minor (OMI) | United States | $1.899B | 18.23 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
| InMode (INMD) | Israel | $1.462B | 7.57 |
| LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
| AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
| Warby Parker (WRBY) | United States | $1.185B | 0.00 |
| AtriCure (ATRC) | United States | $1.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.977B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
| Evolus (EOLS) | United States | $0.668B | 0.00 |
| Quanterix (QTRX) | United States | $0.605B | 0.00 |
| Jin Medical (ZJYL) | China | $0.600B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
| Valneva SE (VALN) | France | $0.528B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
| PetIQ (PETQ) | United States | $0.479B | 17.89 |
| ZimVie (ZIMV) | United States | $0.420B | 25.72 |
| Biote (BTMD) | United States | $0.413B | 3.93 |
| OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
| Surmodics (SRDX) | United States | $0.377B | 40.75 |
| Zynex (ZYXI) | United States | $0.366B | 42.15 |
| Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Veru (VERU) | United States | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
| Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.091B | 0.00 |
| Brainsway (BWAY) | Israel | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| United Health Products (UEEC) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.30 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |